ELN484228 is a potent and selective histone deacetylase 6 (HDAC6) inhibitor utilized in biomedical research, particularly for studying cellular pathways in neurodegeneration, cancer, and inflammatory conditions. It functions as a tool compound to probe HDAC6-specific mechanisms, including microtubule dynamics, aggresome formation, and immune cell modulation. Researchers apply ELN484228 to assess its impact on neuronal protection, reduction of neuroinflammation, inhibition of cancer cell proliferation, and potential in anti-infective therapies, thereby aiding in the elucidation of disease mechanisms and the discovery of novel pharmacological interventions.